These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 23026381)

  • 1. Occurrence and clinical significance of in-hospital acquired thrombocytopenia in patients undergoing transcatheter device closure for congenital heart defect.
    Li P; Chen F; Zhao X; Zheng X; Wu H; Chen S; Qin Y
    Thromb Res; 2012 Dec; 130(6):882-8. PubMed ID: 23026381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction.
    Nikolsky E; Sadeghi HM; Effron MB; Mehran R; Lansky AJ; Na Y; Cox DA; Garcia E; Tcheng JE; Griffin JJ; Stuckey TD; Turco M; Carroll JD; Grines CL; Stone GW
    Am J Cardiol; 2005 Aug; 96(4):474-81. PubMed ID: 16098296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decline in platelet count after percutaneous transcatheter closure of congenital heart disease.
    Zhou D; Zhang X; Pan W; Ge J
    Acta Cardiol; 2013 Aug; 68(4):373-9. PubMed ID: 24187763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Safety and efficacy of a domestic made small-waist ventricular septal defect occluder for transcatheter closure of ruptured aneurysm of the sinus of Valsalva].
    Chen SP; Bai Y; Zhao XX; Qin YW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Apr; 40(4):298-301. PubMed ID: 22801307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of results and economic analysis of surgical and transcatheter closure of perimembranous ventricular septal defect.
    Liu S; Chen F; Ding X; Zhao Z; Ke W; Yan Y; Zhao X; Qin Y
    Eur J Cardiothorac Surg; 2012 Dec; 42(6):e157-62. PubMed ID: 23024232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the markers of platelet and coagulation activation following transcatheter closure of atrial septal defects.
    Rodés-Cabau J; Palacios A; Palacio C; Girona J; Galve E; Evangelista A; Casaldáliga J; Albert D; Picó M; Soler-Soler J
    Int J Cardiol; 2005 Jan; 98(1):107-12. PubMed ID: 15676174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade.
    Kereiakes DJ; Berkowitz SD; Lincoff AM; Tcheng JE; Wolski K; Achenbach R; Melsheimer R; Anderson K; Califf RM; Topol EJ
    Am Heart J; 2000 Jul; 140(1):74-80. PubMed ID: 10874266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Device closure of atrial septal defect: medium-term outcome with special reference to complications.
    Sadiq M; Kazmi T; Rehman AU; Latif F; Hyder N; Qureshi SA
    Cardiol Young; 2012 Feb; 22(1):71-8. PubMed ID: 21740607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of transcatheter closure of atrial septal defects not only in young adults.
    Vijarnsorn C; Durongpisitkul K; Chanthong P; Chungsomprasong P; Soongswang J; Loahaprasitiporn D; Nana A; Kurasirikul S; Nimdet K
    J Interv Cardiol; 2012 Aug; 25(4):382-90. PubMed ID: 22409656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Closure of perimembranous ventricular septal defects with aneurysmal tissue using the Amplazter Duct Occluder I: lessons learned and medium term follow up.
    El Said HG; Bratincsak A; Gordon BM; Moore JW
    Catheter Cardiovasc Interv; 2012 Nov; 80(6):895-903. PubMed ID: 22907908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors.
    Crowther MA; Cook DJ; Meade MO; Griffith LE; Guyatt GH; Arnold DM; Rabbat CG; Geerts WH; Warkentin TE
    J Crit Care; 2005 Dec; 20(4):348-53. PubMed ID: 16310606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Outcome of transcatheter closure of perimembranous ventricular septal defect with modified double-disk occluder device].
    Liu J; You XH; Zhao XX; Hu JQ; Cao J; Xu RL; Wu H; Chen SP; Zhang JL; Zheng X; Qin YW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Apr; 38(4):321-5. PubMed ID: 20654076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter closure of congenital and acquired muscular ventricular septal defects using the Amplatzer device.
    Chessa M; Carminati M; Cao QL; Butera G; Giusti S; Bini RM; Hijazi ZM
    J Invasive Cardiol; 2002 Jun; 14(6):322-7. PubMed ID: 12042624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous atrial septal occluder devices and cardiac erosion: a review of the literature.
    Crawford GB; Brindis RG; Krucoff MW; Mansalis BP; Carroll JD
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):157-67. PubMed ID: 22552868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice.
    Wang TY; Ou FS; Roe MT; Harrington RA; Ohman EM; Gibler WB; Peterson ED
    Circulation; 2009 May; 119(18):2454-62. PubMed ID: 19398666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transcatheter interventional therapy of congenital heart disease: the results of Chinese TIT registry].
    Li JJ; Zhang ZW; Qian MY; Li YF; Wang SS;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Apr; 40(4):283-8. PubMed ID: 22801304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factors influencing the choice of atrial septal occluder for transcatheter closure of secundum atrial septal defects].
    Zhang YS; Lan BD; Li H; He XM; Dai ZX; Wang HC; Zhang J; Li J; DU YJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Nov; 37(11):981-5. PubMed ID: 20137320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of thrombocytopenia and platelet course on pediatric intensive care unit outcomes.
    Krishnan J; Morrison W; Simone S; Ackerman A
    Pediatr Crit Care Med; 2008 Sep; 9(5):502-5. PubMed ID: 18679144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The incidence of thrombocytopenia after cardiopulmonary bypass in children with Down syndrome].
    Karagöl BS; Tokel K; Varan B; Mercan S
    Turk Kardiyol Dern Ars; 2011 Jun; 39(4):283-91. PubMed ID: 21646829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy.
    Oliveira GB; Crespo EM; Becker RC; Honeycutt EF; Abrams CS; Anstrom KJ; Berger PB; Davidson-Ray LD; Eisenstein EL; Kleiman NS; Moliterno DJ; Moll S; Rice L; Rodgers JE; Steinhubl SR; Tapson VF; Ohman EM; Granger CB;
    Arch Intern Med; 2008 Jan; 168(1):94-102. PubMed ID: 18195201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.